Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Evan Secor

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
The American Journal of Tropical Medicine and Hygiene|March 14, 2018
Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional StudyBernard O Abudho, Eric M Ndombi, Bernard Guya, et al.
The American Journal of Tropical Medicine and Hygiene|October 14, 2006
Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in BangladeshCaryn Bern, Josef Amann, Rashidul Haque, et al.
Plos Neglected Tropical Diseases|July 24, 2008
Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposureAgnès-Laurence Chenine, Ela Shai-Kobiler, Lisa N Steele, et al.
AIDS (London, England)|October 18, 2005
Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaquesAgnès-Laurence Chenine, Kathleen A Buckley, Pei-Lin Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2007
High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugeesDrew L Posey, Brian G Blackburn, Michelle Weinberg, et al.
Infection and Immunity|March 23, 2006
Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humansLisa M Ganley-Leal, Pauline N Mwinzi, Catherine B Cetre-Sossah, et al.
Plos One|August 27, 2013
Use of geospatial modeling to predict Schistosoma mansoni prevalence in Nyanza Province, KenyaDana M Woodhall, Ryan E Wiegand, Michael Wellman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2020
Fine-scale heterogeneity in <i>Schistosoma mansoni</i> force of infection measured through antibody responseBenjamin F Arnold, Henry Kanyi, Sammy M Njenga, et al.
International Journal for Parasitology|March 5, 2016
Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western KenyaIsaac O Onkanga, Pauline N M Mwinzi, Geoffrey Muchiri, et al.
Annals of Tropical Medicine and Parasitology|June 14, 2002
Dracunculus medinensis and Schistosoma mansoni contain opiate alkaloidsW Zhu, G Baggerman, W Evan Secor, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
The American Journal of Tropical Medicine and Hygiene|March 14, 2018
Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional StudyBernard O Abudho, Eric M Ndombi, Bernard Guya, et al.
The American Journal of Tropical Medicine and Hygiene|October 14, 2006
Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in BangladeshCaryn Bern, Josef Amann, Rashidul Haque, et al.
Plos Neglected Tropical Diseases|July 24, 2008
Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposureAgnès-Laurence Chenine, Ela Shai-Kobiler, Lisa N Steele, et al.
AIDS (London, England)|October 18, 2005
Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaquesAgnès-Laurence Chenine, Kathleen A Buckley, Pei-Lin Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2007
High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugeesDrew L Posey, Brian G Blackburn, Michelle Weinberg, et al.
Infection and Immunity|March 23, 2006
Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humansLisa M Ganley-Leal, Pauline N Mwinzi, Catherine B Cetre-Sossah, et al.
Plos One|August 27, 2013
Use of geospatial modeling to predict Schistosoma mansoni prevalence in Nyanza Province, KenyaDana M Woodhall, Ryan E Wiegand, Michael Wellman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2020
Fine-scale heterogeneity in <i>Schistosoma mansoni</i> force of infection measured through antibody responseBenjamin F Arnold, Henry Kanyi, Sammy M Njenga, et al.
International Journal for Parasitology|March 5, 2016
Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western KenyaIsaac O Onkanga, Pauline N M Mwinzi, Geoffrey Muchiri, et al.
Annals of Tropical Medicine and Parasitology|June 14, 2002
Dracunculus medinensis and Schistosoma mansoni contain opiate alkaloidsW Zhu, G Baggerman, W Evan Secor, et al.
Pageof 13